Nearly everyone has heard of Rheumatoid Arthritis, a common form of inflammatory arthritis, but hardly anyone has heard of Spondyloarthritis, an inflammatory form of arthritis that is almost as common as Rheumatoid Arthritis.
Learn what Spondyloarthritis means and whom it affects. Consider its related conditions, how the disease can be managed along with facts and figures.
Seronegative arthritis is male predominant, except in the case of Psoriatic Arthritis (PsA) where the male to female ratio is 1:1.
We are a National association to advocate for and support those suffering from Ankylosing Spondylitis, Psoriatic Arthritis, and associated Spondyloarthritis diseases. The Canadian Spondylitis Association is run entirely by volunteers with Spondyloarthritis.
Peripheral Spondyloarthritis affects joints, nails and skin.
More than 4.6 million Canadians live with a form of arthritis. The pain caused by arthritis to those who live with it is wearing and depressing. Arthritis pain can have a severe effect on work, relationships and quality of life.
Psoriatic Arthritis (PsA) is treated the same way as Ankylosing Spondyloarthritis (AS) except some medications work for Peripheral SpA only.
With a broad offering of Support Groups, awareness and connectivity on Social Networks along with Educational Seminars and Events, the Canadian Spondylitis Association has a strong commitment to supporting the Spondylitis Community.
Osteoarthritis is associated with aging whereas inflammatory arthritis can start in children and frequently occurs in young adults.
Discover the various ways you can participate in the Canadian Spondylitis Association and make an impression on our nation for those who suffer with Spondylitis.
Inflammatory arthritis covers a number of autoimmune diseases where the body’s own immune system attacks the joints.
Consider the latest news and events from the Canadian Spondylitis Association, and become a part of something that helps 4.6 Million Canadians.
Cosentyx first Interleukin-17A inhibitor for psoriatic arthritis and ankylosing spondylitis approved by Health Canada
A multifaceted approach for the early clinical identification of axial spondyloarthritis: a study of first degree relatives
AS Health Storylines Mobile App, Self-care for Ankylosing Spondylitis and associated Spondyloarthritis diseases
A Canadian research team (including patients, healthcare providers, researchers and policy makers) is exploring new ways to help people with chronic illness live well.
Effective February 2, 2015 the Quebec Ministry of Health advised that a best lowest price policy will apply for Infliximab and its indications (what diseases it is approved to treat).
Join our mailing list and be the first to hear about news, events and research.